|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 20742 |
FusionGeneSummary for MAN1A2_PTGFRN |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: MAN1A2_PTGFRN | Fusion gene ID: 20742 | Hgene | Tgene | Gene symbol | MAN1A2 | PTGFRN | Gene ID | 10905 | 5738 |
| Gene name | mannosidase alpha class 1A member 2 | prostaglandin F2 receptor inhibitor | |
| Synonyms | MAN1B | CD315|CD9P-1|EWI-F|FPRP|SMAP-6 | |
| Cytomap | 1p12 | 1p13.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | mannosyl-oligosaccharide 1,2-alpha-mannosidase IBalpha-1,2-mannosidase IBalpha1,2-mannosidaseprocessing alpha-1,2-mannosidase IB | prostaglandin F2 receptor negative regulatorCD9 partner 1glu-Trp-Ile EWI motif-containing protein Fprostaglandin F2-alpha receptor regulatory proteinprostaglandin F2-alpha receptor-associated protein | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | O60476 | Q9P2B2 | |
| Ensembl transtripts involved in fusion gene | ENST00000356554, ENST00000482811, | ENST00000393203, ENST00000496699, | |
| Fusion gene scores | * DoF score | 11 X 12 X 6=792 | 3 X 3 X 3=27 |
| # samples | 19 | 3 | |
| ** MAII score | log2(19/792*10)=-2.05950101174866 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: MAN1A2 [Title/Abstract] AND PTGFRN [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | UCEC | TCGA-FI-A3PV-01A | MAN1A2 | chr1 | 117984947 | + | PTGFRN | chr1 | 117529423 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000356554 | ENST00000393203 | MAN1A2 | chr1 | 117984947 | + | PTGFRN | chr1 | 117529423 | + |
| 5CDS-intron | ENST00000356554 | ENST00000496699 | MAN1A2 | chr1 | 117984947 | + | PTGFRN | chr1 | 117529423 | + |
| intron-3CDS | ENST00000482811 | ENST00000393203 | MAN1A2 | chr1 | 117984947 | + | PTGFRN | chr1 | 117529423 | + |
| intron-intron | ENST00000482811 | ENST00000496699 | MAN1A2 | chr1 | 117984947 | + | PTGFRN | chr1 | 117529423 | + |
Top |
FusionProtFeatures for MAN1A2_PTGFRN |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| MAN1A2 | PTGFRN |
| Involved in the maturation of Asn-linkedoligosaccharides. Progressively trim alpha-1,2-linked mannoseresidues from Man(9)GlcNAc(2) to produce Man(5)GlcNAc(2). | Inhibits the binding of prostaglandin F2-alpha (PGF2-alpha) to its specific FP receptor, by decreasing the receptornumber rather than the affinity constant. Functional coupling withthe prostaglandin F2-alpha receptor seems to occur (Bysimilarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | MAN1A2 | chr1:117984947 | chr1:117529423 | ENST00000356554 | + | 6 | 13 | 2_36 | 316 | 642 | Topological domain | Cytoplasmic |
| Hgene | MAN1A2 | chr1:117984947 | chr1:117529423 | ENST00000356554 | + | 6 | 13 | 37_57 | 316 | 642 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
| Tgene | >PTGFRN | chr1:117984947 | chr1:117529423 | ENST00000393203 | + | 7 | 9 | 854_879 | 824 | 880 | Topological domain | Cytoplasmic |
| Tgene | >PTGFRN | chr1:117984947 | chr1:117529423 | ENST00000393203 | + | 7 | 9 | 833_853 | 824 | 880 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | >MAN1A2 | chr1:117984947 | chr1:117529423 | ENST00000356554 | + | 6 | 13 | 58_641 | 316 | 642 | Topological domain | Lumenal |
| Tgene | PTGFRN | chr1:117984947 | chr1:117529423 | ENST00000393203 | + | 7 | 9 | 149_268 | 824 | 880 | Domain | Note=Ig-like C2-type 2 |
| Tgene | PTGFRN | chr1:117984947 | chr1:117529423 | ENST00000393203 | + | 7 | 9 | 26_129 | 824 | 880 | Domain | Note=Ig-like C2-type 1 |
| Tgene | PTGFRN | chr1:117984947 | chr1:117529423 | ENST00000393203 | + | 7 | 9 | 276_394 | 824 | 880 | Domain | Note=Ig-like C2-type 3 |
| Tgene | PTGFRN | chr1:117984947 | chr1:117529423 | ENST00000393203 | + | 7 | 9 | 406_536 | 824 | 880 | Domain | Note=Ig-like C2-type 4 |
| Tgene | PTGFRN | chr1:117984947 | chr1:117529423 | ENST00000393203 | + | 7 | 9 | 544_662 | 824 | 880 | Domain | Note=Ig-like C2-type 5 |
| Tgene | PTGFRN | chr1:117984947 | chr1:117529423 | ENST00000393203 | + | 7 | 9 | 688_813 | 824 | 880 | Domain | Note=Ig-like C2-type 6 |
| Tgene | PTGFRN | chr1:117984947 | chr1:117529423 | ENST00000393203 | + | 7 | 9 | 424_427 | 824 | 880 | Motif | Note=Endoplasmic reticulum retention signal |
| Tgene | PTGFRN | chr1:117984947 | chr1:117529423 | ENST00000393203 | + | 7 | 9 | 703_705 | 824 | 880 | Motif | Cell attachment site |
| Tgene | PTGFRN | chr1:117984947 | chr1:117529423 | ENST00000393203 | + | 7 | 9 | 26_832 | 824 | 880 | Topological domain | Extracellular |
Top |
FusionGeneSequence for MAN1A2_PTGFRN |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_MAN1A2_ENST00000356554_chr1_117984947_+_PTGFRN_ENST00000393203_chr1_117529423_+_372aa MTTPALLPLSGRRIPPLNLGPPSFPHHRATLRLSEKFILLLILSAFITLCFGAFFFLPDSSKHKRFDLGLEDVLIPHVDAGKGAKNPGVF LIHGPDEHRHREEEERLRNKIRADHEKALEEAKEKLRKSREEIRAEIQTEKNKVVQEMKIKENKPLPPVPIPNLVGIRGGDPEDNDIREK REKIKEMMKHAWDNYRTYGWGHNELRPIARKGHSPNIFGSSQMGATIVDALDTLYIMGLHDEFLDGQRWIEDNLDFSVNSEVSVFEVNIR FIGGLLAAYYLSGEEIFKIKAVQLAEKLLPAFNTPTGIPWAMVNLKSAERLQVSLADRRRSVHGHRAPVLSHRVLQLPLVLXEGGSGDTA |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_MAN1A2_ENST00000356554_chr1_117984947_+_PTGFRN_ENST00000393203_chr1_117529423_+_1117nt ATGACTACCCCAGCCCTGCTGCCCCTCTCTGGACGTAGGATACCACCTCTGAACCTGGGGCCGCCTTCCTTCCCACATCACAGGGCTACC TTGAGACTTTCTGAGAAGTTTATTCTTCTCCTTATTCTTAGTGCCTTCATCACTCTGTGTTTTGGGGCATTCTTTTTCCTTCCAGACTCT TCAAAACACAAACGCTTTGATTTGGGTTTAGAAGATGTGTTAATTCCACATGTAGATGCCGGTAAAGGGGCTAAAAACCCCGGAGTCTTC CTGATCCATGGACCCGATGAACATAGACACAGGGAAGAGGAAGAACGTCTGAGAAATAAAATTCGAGCTGATCATGAGAAGGCCTTGGAA GAAGCAAAAGAAAAATTAAGAAAGTCAAGAGAGGAAATTCGAGCAGAAATTCAGACAGAGAAAAATAAGGTAGTCCAAGAAATGAAGATA AAAGAGAACAAGCCACTGCCACCAGTCCCTATTCCCAACCTTGTAGGAATACGTGGTGGAGACCCAGAAGATAATGACATAAGAGAGAAA AGGGAAAAAATTAAAGAGATGATGAAACATGCTTGGGATAACTATAGGACATATGGGTGGGGACATAATGAACTCAGACCTATTGCAAGG AAAGGACACTCCCCTAACATATTTGGAAGTTCACAAATGGGTGCTACCATAGTAGATGCTTTGGATACCCTTTATATCATGGGACTTCAT GATGAATTCCTAGATGGGCAAAGATGGATTGAAGACAACCTTGATTTCAGTGTGAATTCAGAGGTGTCTGTGTTTGAAGTCAACATTCGA TTTATTGGAGGCCTACTTGCAGCATATTACCTATCAGGAGAGGAGATATTCAAGATTAAAGCAGTGCAATTGGCTGAGAAACTCCTTCCT GCCTTTAACACACCTACTGGGATTCCTTGGGCAATGGTGAATTTGAAAAGTGCTGAACGCCTTCAAGTATCCCTTGCTGATCGGCGTCGG TCTGTCCACGGTCATCGGGCTCCTGTCCTGTCTCATCGGGTACTGCAGCTCCCACTGGTGTTGTAAGAAGGAGGTTCAGGAGACACGGCG |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_MAN1A2_ENST00000356554_chr1_117984947_+_PTGFRN_ENST00000393203_chr1_117529423_+_5243nt AGACCCGTGCGGTAGCAACAGCGGCGGCGGCCGCGGCGGCTGGCCGGACTCAGGTGTTTCGGACGCTATTGCCCTTCGCGCCAGCCGTCG AGTGGGCAGCAGCGGGACTCAGCCGGGCGCCAGGTTCCTGCCAGGCAGCGCCGGGAAGCGCGGGCGGCCGAGAACTCCTTCCTGCTACTT CGCCCAGCGCCGCTGCTTCGGCTTCCCAGCGAAGTGGGAGACCTTCCTCCCTGTTTGCAGACGTCCGTGGGAGACCCTTATTTTTTCCAC CGCTAAGGTTAAGAGATTCTGGAATAGAAGCGTCGAAGGAGATCAAGTGAACCTTCTACAACTCCTCGGATGTCGCCAGTCTCCCTTTCG GGGCGGAAGACTACGTTTGAGCATCTCACTGAGGTGCAGGAATGGAAGAACCCACCTTGCAGCTTTTCTGCAGTGTGGCTTGCCTGATCT ACCCCTAGGAATGAAGAGGAGGCTTGTAATAATCCGATGAAGTACAGATGTTGAAGAGGATATCGCAGGACCTAAACTTGTGATCGTTTG GGGGAGGTCACACACGTTTCTGAGTGGGAATGGATGGGCGTGAATGACGTGCCCTCTTAAAAAGCACAACAGTCCTTTAAGAGGAGCAAA ATTGAGTTTTCCCATTTTGGCCAAGATTTTGAAGACAGTTCAATGTATTCTACATTTGACATAAGATGAGAACTTTCTAAAGTATTCTCT CCAAGAGCGTAAACGATGACTACCCCAGCCCTGCTGCCCCTCTCTGGACGTAGGATACCACCTCTGAACCTGGGGCCGCCTTCCTTCCCA CATCACAGGGCTACCTTGAGACTTTCTGAGAAGTTTATTCTTCTCCTTATTCTTAGTGCCTTCATCACTCTGTGTTTTGGGGCATTCTTT TTCCTTCCAGACTCTTCAAAACACAAACGCTTTGATTTGGGTTTAGAAGATGTGTTAATTCCACATGTAGATGCCGGTAAAGGGGCTAAA AACCCCGGAGTCTTCCTGATCCATGGACCCGATGAACATAGACACAGGGAAGAGGAAGAACGTCTGAGAAATAAAATTCGAGCTGATCAT GAGAAGGCCTTGGAAGAAGCAAAAGAAAAATTAAGAAAGTCAAGAGAGGAAATTCGAGCAGAAATTCAGACAGAGAAAAATAAGGTAGTC CAAGAAATGAAGATAAAAGAGAACAAGCCACTGCCACCAGTCCCTATTCCCAACCTTGTAGGAATACGTGGTGGAGACCCAGAAGATAAT GACATAAGAGAGAAAAGGGAAAAAATTAAAGAGATGATGAAACATGCTTGGGATAACTATAGGACATATGGGTGGGGACATAATGAACTC AGACCTATTGCAAGGAAAGGACACTCCCCTAACATATTTGGAAGTTCACAAATGGGTGCTACCATAGTAGATGCTTTGGATACCCTTTAT ATCATGGGACTTCATGATGAATTCCTAGATGGGCAAAGATGGATTGAAGACAACCTTGATTTCAGTGTGAATTCAGAGGTGTCTGTGTTT GAAGTCAACATTCGATTTATTGGAGGCCTACTTGCAGCATATTACCTATCAGGAGAGGAGATATTCAAGATTAAAGCAGTGCAATTGGCT GAGAAACTCCTTCCTGCCTTTAACACACCTACTGGGATTCCTTGGGCAATGGTGAATTTGAAAAGTGCTGAACGCCTTCAAGTATCCCTT GCTGATCGGCGTCGGTCTGTCCACGGTCATCGGGCTCCTGTCCTGTCTCATCGGGTACTGCAGCTCCCACTGGTGTTGTAAGAAGGAGGT TCAGGAGACACGGCGCGAGCGCCGCAGGCTCATGTCGATGGAGATGGACTAGGCTGGCCCGGGAGGGGAGTGACAGAGGGACGTTCTAGG AGCAATTGGGGCAAGAAGAGGACAGTGATATTTTAAAACAAAGTGTGTTACACTAAAAACCAGTCCTCTCTAATCTCAGGTGGGACTTGG CGCTCTCTCTTTTCTGCATGTCAAGTTCTGAGCGCGGACATGTTTACCAGCACACGGCTCTTCTTCCCACGGCACTTTCTGATGTAACAA TCGAGTGTGTGTTTTCCCAACTGCAGCTTTTTAATGGTTAACCTTCATCTAATTTTTTTTCTCCCACTGGTTTATAGATCCTCTGACTTG TGTGTGTTTATAGCTTTTGTTTCGCGGGGTTGTGGTGAGGAAGGGGTGATGGCATGCGGAGTTCTTTATCTTCAGTGAGAATGTGCCTGC CCGCCTGAGAGCCAGCTTCCGCGTTGGAGGCACGTGTTCAGAGAGCTGCTGAGCGCCACCCTCTACCCGGCTGACAGACAACACAGACCT GTGCCGAAGGCTAATTTGTGGCTTTTACGACCCTACCCCACCCCCTGTTTTCAGGGGTTTAGACTACATTTGAAATCCAAACTTGGAGTA TATAACTTCTTATTGAGCCCAACTGCTTTTTTTTTTTTTTTTTTTGCTTCTCTGCCCCTTTTCCATTTCTTTTGTATTTGTTTTCTGTGA GAGCACTGAAATGGCAGCCCTGGAATCTACAATTTGGCTCTCCACTGAGCACCTTATCTTGCCACCTTAGCCTTAAGAATGAATATGAAG AAAAATACACAGCCACCTCTGTCCAGGGCAGTAAGAAGGGCTGCAAGGAAGGGGAGGATGGGGACAAGGAAAGGATCAGATACCTGCTCC AGTAGTTGTGAGGCCACTGTGTCTCAGGGGACTCCAGGAGGAGCAGAAGAGGGATCCCACGAAGTTATTCTTACGCAGCTGGGGCCAGGA GGGTCAGAGTGGTGCCAGGTGCAAGTTAGGCTAAAGAAGCCACCACTATTCCTCTCTCTTGCCCATTGTGGGGGGCAAAGGCATTGGTCA CCAAGAGTCTTGCAGGGGGACCCACAGATATGCCATGTCCTTCACACGTGCTTGGGCTCCTTAACCTGAAGGCAAATTGCTACTTGCAAG ACTGACTGACTTCAAGGAATCAGAAATTACCTAGAAGCACCATGTTTTTTCTATGACCTTTTCAGTCCTTCAGGTCATTTTAAGGTCCAC TGCAGGGGGTTAGTGAGAAAGGGTATACTTTGTGGTATGTTTTGCTTTCCTAATAGGGACATGAAGGAAACCCAGCAATTTGCTGTTATG TGAATGGCCTGTAGAGCAGAGTCAAGAGCGGTGTGCTTTGCCCGACTGCTCCCATCAGGAATAGGAGAGTAGACAGAGATCTTCCACATC CCAGGCTTCTGCTGCTGCTTTAAAAGCTCTGTCCTTGGAGCCTCCCGCTCCCTGAAGTGTCTCGCCCCCTGCACAGCACTGGCCTTTCGG AAGCATCCCAGTAGGGTTTTCTGAGGCTCGCTGGTGACTCATGCCCTAATTGCAATCCTCTGCTTTTATCTTGACTTTGAAGGATCTAAC ACTGCTCTCTCTTCCAAAGGGGAAAAAAAGATTCATTTGTTTTGAGCAATAAACTAATACAAAATGATGGCCATTCATGTGCAGCTCTTT GTCACCATGGGCCGGATGAGTTGTGCTCCTCCTGGCTCACCATTTCCCCCTGCTCCCCCACAGCCGGTTCTGCACTTATCACCGAGTCGC CCCTGGAAGCAGATTCCCATTGAGTTTTCCCCACCAAGGGGACCATGCACATGGTAGAAACATTAGATTCTGCATTGACAGTAGCCTTTC CTTGGCCCGGGCCTGTGGTGGGAAGACGGGCAACAAGTATACCCCACCAGGGCCTGAGTGACTAGAGGAAGAGGACGAGGCCTTGTTGGC ACTAGATTTGGGTATTTTCTGCATGTCATAACATATCCTAACTGCTATTTCAGAAGAGGCAGCTTGTAGGTGATTGTACAAGTGAGAATT AAAGAGAGAACAGATATTTAAACAGGTGCTGTATTAGTAACAGCCAGTGCCCTTTCAGCCCTTGCATCTATTAAAAGGAGATTCAGGATT TTATTGGCACAGGCCCTTCTTAGTAGGAAGAAAGGGTGCTTAGCTTTGGACCTGACCGGGTGTGTGTAAAACCATGGACTGAGTCACAGC AGACACTCGATGGTGGTAAATGTGATGGGTGCTTACACACTGTACCTTTTCCTTTCATACTGATGCTGCAGTTCAGGGCTGGAGTTGTTA AGGCATTGACCTCCACCCACCTGCCCCATGTCCACTGGGCTGCCCAAGCTGCATGTCACCTGAGGGCTGGCAGGAAGGGGCGAGAAATCC CAGGGCATTGTACCAAGGACCTAGTTCCTTCTAGGGATATAAATTTCCAGGAATGTGTATTTTTAATGTGGTGAGATGCACTCTTTTGTT GTACCAAATAGGGCTCCCCACCCCACCCCTGCGACAAGTGCTCTTCTAGAACAGGTTCCTACCAGCAGCACTGGTGTGAATGAAAGAGAG ACCCAGCCGCGTCTCACACAGGTGGAATTGCACTTCTTAACAAAAAGGAACTTTATAAAAGTTTGGGATTTTTTTTCCTAATCATAAAAA TAGCCCCAGAAAGAGCCTAAGCTATGTTCAGATAGAAGCCTCGAAATTCCTGTAAATTGTTTACTTTATGATGTTTACATACACGTTTCA CTTTGAAAAAAAATGCAAATCGACTTTTTAACAACTGTTGAGATGTTTCATGGGACAGTAGAACTCTGACTCACCAACTGGGCTAAATTT TAATTTAAAAATGTATTTATTTGAGTGTCTTTCCCCCCCTCACCCTCACCATCTGAGGGGCTCCCTGAGATCTTGGTAGAGGAGGCCCCT CCTGCCCAGACCTTCGTTTGTTTCCCCGGTGGCCCTTGCTTCTTGCTTTGCAGACTGCCTGCAGCCATGATTTTGTCACTGACATCTGTG AGCCAAAGACTGAGCCTTTTTGGCAGGAATAATAAGCAATACTACACAACTTGCTACTTTCAGAAAACTTTTTTTTAGCTTCACCGATGA CAACAGAGGAAGAAGGGAACTGGGATTTGGGTAAGTTCTCCTCCACTGTTTGACCAAATTCTCAGTGATAAATATGTGTGCAGATCCCTA GAAGAGAAAACGCTGACTTTCTTTTTAAGTGTGGCACATAAGGATCTGCAGAATTTTCCGTAGACAAAGAAAGGATCTTGTGTATTTTTG TCCATATCCAATGTTATATGAACTAATTGTATTGTTTTATACTGTGACCACAAATATTATGCAATGCACCATTTGTTTTTTATTTCATTA |
Top |
FusionGenePPI for MAN1A2_PTGFRN |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| MAN1A2 | SMAD9, CLDND1, CD1B, SCARA3, CLU, C5AR2, CD1E, SCGB2A2, TMEM30B, IL13RA2, ADAM32, PMEL, B4GAT1, TLR5, TRHDE, PTPRO | PTGFRN | CD151, CD81, CD9, CD63, CD82, FBXO6, RPL6, LGALS3, LGALS8, LGALS9, A4GALT, ATP1B4, BTNL8, SIAE, TSPAN2, SCGB1D1, ST8SIA4 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MAN1A2_PTGFRN |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for MAN1A2_PTGFRN |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|